Muscle relaxation during anesthesia is achieved by blocking neuromuscular transmission at the neuromuscular junction using drugs called neuromuscular blocking agents.
These agents prevent acetylcholine from activating nicotinic receptors on skeletal muscle, so the muscle cannot contract.
This produces controlled, reversible paralysis that allows intubation, mechanical ventilation, and optimal surgical conditions.
Muscle relaxation is not caused by anesthetic gases or IV anesthetics alone. Instead, it is produced by neuromuscular blocking agents, which act peripherally at the neuromuscular junction.
[How anesthetics, analgesics, and muscle relaxants interact]
Key features:
Supported by: Succinylcholine is the main depolarizing NMBA used in anesthesia, with rapid onset and short duration. pmc.ncbi.nlm.nih.gov
These agents competitively block acetylcholine receptors without activating them.
Supported by: Non‑depolarizing agents competitively inhibit acetylcholine at nicotinic receptors, producing neuromuscular blockade. mdpi.com
This effect is peripheral, not central — NMBAs do not cause unconsciousness or analgesia.
Anesthesiologists use Train‑of‑Four (TOF) nerve stimulation to quantify blockade.
| Mechanism | Example Drugs | How It Works | Onset | Duration | Reversible? |
|---|---|---|---|---|---|
| Depolarizing block | Succinylcholine | Persistent depolarization → paralysis | Seconds | Minutes | No pharmacologic reversal |
| Non‑depolarizing block | Rocuronium, Vecuronium, Cisatracurium | Competitive ACh receptor blockade | 1–3 min | 20–60 min | Yes (neostigmine, sugammadex) |